Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (151-160 of 1,111) with videos related to

Pageof 112
Sort By:
Cardiovascular Therapeutics|April 16, 2013
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registryZanfina Ademi, Molla M Huq, Danny Liew, et al.
European Heart Journal. Acute Cardiovascular Care|May 10, 2023
Strategies to mitigate emergency department crowding and its impact on cardiovascular patientsChristopher W Baugh, Yonathan Freund, Philippe Gabriel Steg, et al.
Journal of Clinical Periodontology|April 4, 2018
Self-report assessment of severe periodontitis: Periodontal screening score developmentMaria Clotilde Carra, Alice Gueguen, Frédérique Thomas, et al.
Journal of Cardiac Failure|March 31, 2009
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?Jay Cohn, John G F Cleland, Jacobus Lubsen, et al.
International Journal of Cardiology|December 30, 2011
Recurrent acute coronary syndromes are associated with increased shear induced platelet aggregation. A case-control studyNadine Ajzenberg, Grégory Ducrocq, Reza Farnoud, et al.
Circulation|November 19, 2003
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trialPhilippe Gabriel Steg, Eric Bonnefoy, Sylvie Chabaud, et al.
Chest|November 12, 2002
MRI of acute myocarditis: a comprehensive approach based on various imaging sequencesJean-Pierre Laissy, Benoît Messin, Olivier Varenne, et al.
Thrombosis and Haemostasis|March 8, 2003
Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseLoïc Vincent, Patricia Albanese, Heidi Bompais, et al.
Plos One|April 28, 2015
Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY RegistryLaurent Fauchier, Nicola Greenlaw, Roberto Ferrari, et al.
Clinical Cardiology|June 1, 2017
Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery diseaseEmmanuel Sorbets, Nicola Greenlaw, Roberto Ferrari, et al.
Pageof 112

Showing results (151-160 of 1,111) with videos related to

Sort By:
Pageof 112
Cardiovascular Therapeutics|April 16, 2013
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registryZanfina Ademi, Molla M Huq, Danny Liew, et al.
European Heart Journal. Acute Cardiovascular Care|May 10, 2023
Strategies to mitigate emergency department crowding and its impact on cardiovascular patientsChristopher W Baugh, Yonathan Freund, Philippe Gabriel Steg, et al.
Journal of Clinical Periodontology|April 4, 2018
Self-report assessment of severe periodontitis: Periodontal screening score developmentMaria Clotilde Carra, Alice Gueguen, Frédérique Thomas, et al.
Journal of Cardiac Failure|March 31, 2009
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?Jay Cohn, John G F Cleland, Jacobus Lubsen, et al.
International Journal of Cardiology|December 30, 2011
Recurrent acute coronary syndromes are associated with increased shear induced platelet aggregation. A case-control studyNadine Ajzenberg, Grégory Ducrocq, Reza Farnoud, et al.
Circulation|November 19, 2003
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trialPhilippe Gabriel Steg, Eric Bonnefoy, Sylvie Chabaud, et al.
Chest|November 12, 2002
MRI of acute myocarditis: a comprehensive approach based on various imaging sequencesJean-Pierre Laissy, Benoît Messin, Olivier Varenne, et al.
Thrombosis and Haemostasis|March 8, 2003
Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseLoïc Vincent, Patricia Albanese, Heidi Bompais, et al.
Plos One|April 28, 2015
Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY RegistryLaurent Fauchier, Nicola Greenlaw, Roberto Ferrari, et al.
Clinical Cardiology|June 1, 2017
Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery diseaseEmmanuel Sorbets, Nicola Greenlaw, Roberto Ferrari, et al.
Pageof 112